Skip to Content

Binosto

In the US, Binosto (alendronate systemic) is a member of the drug class bisphosphonates and is used to treat Aseptic Necrosis, Osteoporosis, Paget's Disease and Prevention of Osteoporosis.

US matches:

UK matches:

Ingredient matches for Binosto

Alendronate

Alendronic Acid is reported as an ingredient of Binosto in the following countries:

  • Italy
  • Portugal

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Binosto in the following countries:

  • Spain
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide